Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Cardinal Health Inc. Revenue & Financial Statements
Cardinal Health Inc. reported revenue of $222.6B for the fiscal year ended June 30, 2025, down 1.9% year over year, with net income of $1.6B and diluted EPS of $6.45.
- Company
- Cardinal Health Inc. CAH · NYSE
- Latest fiscal year
- FY ended Jun 30, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 162.5B | 181.4B | 205.0B | 226.8B | 222.6B |
| Cost of revenue | 155.7B | 174.8B | 198.1B | 219.4B | 214.4B |
| Gross profit | 6.8B | 6.5B | 6.9B | 7.4B | 8.2B |
| Operating income | 472.0M | (596.0M) | 727.0M | 1.2B | 2.3B |
| Pretax income | 370.0M | 231.0M | 347.0M | 309.0M | 386.0M |
| Net income | 681.0M | (1.0B) | 224.0M | 836.0M | 1.6B |
| Diluted EPS | 2.08 | -3.35 | 1.00 | 3.45 | 6.45 |
| EBITDA | 1.3B | 96.0M | 1.4B | 2.0B | 3.1B |
Quarterly
| USD | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 54.9B | 59.7B | 52.3B | 55.3B | 54.9B | 60.2B | 64.0B | 65.6B |
| Cost of revenue | 53.0B | 57.9B | 50.4B | 53.3B | 52.8B | 58.0B | 61.7B | 63.2B |
| Gross profit | 1.9B | 1.9B | 1.9B | 1.9B | 2.1B | 2.2B | 2.3B | 2.4B |
| Operating income | 367.0M | 408.0M | 568.0M | 549.0M | 730.0M | 428.0M | 668.0M | 707.0M |
| Pretax income | 341.0M | 396.0M | 541.0M | 511.0M | 665.0M | 384.0M | 598.0M | 630.0M |
| Net income | 253.0M | 229.0M | 428.0M | 375.0M | 510.0M | 260.0M | 446.0M | 471.0M |
| Diluted EPS | — | — | 1.70 | — | — | — | 1.88 | — |
| EBITDA | 544.0M | 594.0M | 750.0M | — | 937.0M | 637.0M | 901.0M | 941.0M |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2023 | FY2024 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|
| Total assets | — | 45.1B | — | 53.1B | — |
| Current assets | — | 34.9B | — | 36.4B | — |
| Cash & equivalents | — | 5.1B | — | 3.9B | — |
| Total liabilities | — | — | — | — | — |
| Current liabilities | — | 35.6B | — | 38.9B | — |
| Long-term debt | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Stockholders’ equity | — | (3.2B) | — | (2.8B) | — |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 2.4B | 3.1B | 2.8B | 3.8B | 2.4B |
| Investing cash flow | (378.0M) | 567.0M | (454.0M) | (1.8B) | (5.6B) |
| Financing cash flow | (1.3B) | (2.5B) | (3.1B) | (847.0M) | 1.9B |
| Capital expenditure | 400.0M | 387.0M | 481.0M | 511.0M | 547.0M |
| Free cash flow | 2.0B | 2.7B | 2.4B | 3.3B | 1.9B |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 89.0M | 81.0M | 96.0M | 121.0M | 244.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every CAH filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.